GLYPROLINE PEPTIDE PHARMACODYNAMICS IN RATS IN THE SETTING OF METABOLIC SYNDROME BY THE PARAMETERS OF LIPID METABOLISM AND TROMBOELASTOGRAMMA
Open Access
- 30 November 2019
- journal article
- Published by Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency in Journal Biomed
- No. 4,p. 58-66
Abstract
In this study, experimental data on the biological action of glyproline peptides — Pro-Gly-Pro, Pro-ArgPro, Arg-Pro-Gly-Pro and Pro-Gly-Pro-Leu — on the processes of blood coagulation and lipid metabolism were obtained using animal models of metabolic syndrome. Under the conditions of increased blood clotting and hypercholesterolemia, the regulatory peptides under study were administered intranasally for 7 days once every 24 hours. 20 hours after the last peptide administration, thromboelastogram parameters confi rmed the restoration of the functional state of the coagulating and anticoagulant systems. In addition, a simultaneous positive shift in the parameters of lipid metabolism was observed. These changes lasted for 7 days following the withdrawal of the drugs. It is found that the biological action of the peptides under study consists in their simultaneous regulatory impact on the processes of hemostasis and lipid metabolism.Keywords
This publication has 11 references indexed in Scilit:
- Mechanisms for glyproline protection in hypercholesterolemiaPathophysiology, 2015
- Mature coconut water exhibits antidiabetic and antithrombotic potential via L-arginine-nitric oxide pathway in alloxan induced diabetic ratsJournal of Basic and Clinical Physiology and Pharmacology, 2015
- Effect of the PRO-GLY-PRO peptide on hemostasis and lipid metabolism in rats with hypercholesterolemiaDoklady Biological Sciences, 2013
- Gut-liver interaction in triglyceride-rich lipoprotein metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Losartan and Pioglitazone Ameliorate Nephropathy in Experimental Metabolic Syndrome RatsBiological and Pharmaceutical Bulletin, 2011
- Relationship of Indices of Inflammation and Thrombogenesis to Arrhythmia Burden in Paroxysmal Atrial FibrillationChest, 2010
- High-Density Lipoprotein Cholesterol and Left Ventricular Mass Index in Peritoneal DialysisPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2008
- Peptides and pseudopeptides incorporating D‐Phe–Pro–Arg and Arg–Gly–Asp lead sequences as potential antithrombotic agentsJournal of Peptide Science, 2008
- Revisiting the metabolic syndromeMedical Journal of Australia, 2006
- Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceJAMA, 2003